Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency (2011)
- Authors:
- USP affiliated authors: ANTONINI, SONIR ROBERTO RAUBER - FMRP ; MENDONÇA, BERENICE BILHARINHO DE - FM ; JORGE, ALEXANDER AUGUSTO DE LIMA - FM
- Unidades: FMRP; FM
- DOI: 10.1038/tpj.2011.13
- Subjects: FARMACOGENÉTICA; NANISMO; VARIAÇÃO GENÉTICA; HORMÔNIO DO CRESCIMENTO (DEFICIÊNCIA;TERAPIA;USO)
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: online, 2011
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
COSTALONGA, Everlayny Fiorot et al. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency. The Pharmacogenomics Journal, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.13. Acesso em: 13 mar. 2026. -
APA
Costalonga, E. F., Antonini, S. R. R., Guerra Júnior, G., Coletta, R. R. D., Franca, M. M., Braz, A. F., et al. (2011). Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency. The Pharmacogenomics Journal. doi:10.1038/tpj.2011.13 -
NLM
Costalonga EF, Antonini SRR, Guerra Júnior G, Coletta RRD, Franca MM, Braz AF, Mendonça BB de, Arnhold IJP, Jorge AA de L. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency [Internet]. The Pharmacogenomics Journal. 2011 ;[citado 2026 mar. 13 ] Available from: https://doi.org/10.1038/tpj.2011.13 -
Vancouver
Costalonga EF, Antonini SRR, Guerra Júnior G, Coletta RRD, Franca MM, Braz AF, Mendonça BB de, Arnhold IJP, Jorge AA de L. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency [Internet]. The Pharmacogenomics Journal. 2011 ;[citado 2026 mar. 13 ] Available from: https://doi.org/10.1038/tpj.2011.13 - Genetic Predictors of Long-Term Response to Growth Hormone (GH) Therapy in Children With GH Deficiency and Turner Syndrome: the influence of a SOCS2 polymorphism
- Pathogenic copy number variants in patients with congenital hypopituitarism associated with complex phenotypes
- Baixa estatura desproporcional por mutações no gene SHOX
- Novel Mutations (p.G6R and p.R511W) in IGF1R Gene in Children Born Small for Gestational Age (SGA) Without Catch-up Growth
- Growth Hormone (GH) Pharmacogenetics: Positive Influence of GH Receptor (GHR) Exon 3 Deleted Allele (d3) on First-year Growth Velocity and Final Height in Patients with Turner Syndrome (TS) Treated with Recombinant Human GH (rhGH)
- Autosomal recessive (type I) is more frequent than autosomal dominant (type II) isolated growth hormone deficiencyin acohort of Brazilian patients
- The Sitting Height/Height Ratio for Age in Healthy and Short Individuals and Its Potential Role in Selecting Short Children for SHOX Analysis
- ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome
- Molecular analysis of brazilian patients with combined pituitary hormone deficiency and orthotopic posterior pituitary lobe reveals eight different PROP1 alterations with three novel mutations
- Evaluation of SHOX defects in the era of next-generation sequencing
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
